STOCK PURCHASE AGREEMENT BY AND AMONG EAGLE PHARMACEUTICALS, INC. (as “Buyer”), ARSIA THERAPEUTICS, LLC (the “Seller”), ARSIA THERAPEUTICS, INC. (the “Company”), AMY SCHULMAN (solely in her capacity as “Seller Representative”), AND The Parties that...Stock Purchase Agreement • November 14th, 2016 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of November 10, 2016, is by and among Eagle Pharmaceuticals, Inc., a Delaware corporation (“Buyer”); Arsia Therapeutics, LLC a Delaware limited liability company (“Seller”); Arsia Therapeutics, Inc., a Delaware corporation and wholly owned subsidiary of Seller (the “Company”); in her capacity as representative of the Seller, Amy Schulman (the “Seller Representative”); and each person that executes a Joinder Agreement (as defined herein) in the form of Exhibit D/Exhibit D-1 (the “Equityholder Indemnitors”). Buyer, Seller, the Company, the Seller Representative and the Equityholder Indemnitors are sometimes collectively referred to herein as the “Parties.” Any defined terms not otherwise defined in a particular section shall have the meanings set forth in ARTICLE 11.
